Search results
Health Benefits of Mangosteen
Health via Yahoo News· 6 days agoIt's important to note that this study was relatively short, focused exclusively on a small number of female participants, and utilized an open-label...
MannKind advances new inhaled NTM lung disease treatment By Investing.com
Investing.com· 8 hours agoMannKind (NASDAQ:MNKD) Corporation (NASDAQ:MNKD), a biopharmaceutical company, announced today the...
Smokers, Former Smokers May Gain From Switch to Plant-Based Diet
WFMZ Eastern Pennsylvania and Western New Jersey· 9 hours agoCurrent and former smokers might lower their risk for emphysema if they adopt a highly nutritional...
Smokers, Former Smokers May Gain From Switch to Plant-Based Diet
US News & World Report· 9 hours agoCurrent and former smokers might lower their risk for emphysema if they adopt a highly nutritional plant-based diet, a new study shows. People with a history of smoking who adopted a plant-based ...
The Lundquist Institute Receives $2.6 Million Grant from U.S. Army Medical Research Acquisition...
Morningstar· 5 days agoThe research project is led by Dr. Harry Rossiter, an investigator at TLI and Professor at the David Geffen School of Medicine at UCLA. The project aims to develop wearable multiplex biosensors ...
RSV vaccine boosts Monroe County's Sanofi Pasteur
WFMZ Eastern Pennsylvania and Western New Jersey· 4 days agoSanofi, a pharmaceutical company with Monroe County operations, reported a 2.4% gain in first-quarter revenue on Thursday, as sales of vaccines and the...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 days agoThe company is working on a drug to treat liver fibrosis due to hepatitis B and metabolic...
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
WTNH-TV New Haven· 9 hours agoTheravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024. An accompanying conference ...
MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation...
Benzinga· 9 hours ago"Oral clofazimine has been utilized as a treatment option for patients living with NTM lung disease and we believe that by reducing the dose and administering it directly ...
Lucius Partners, LLC Portfolio Company AerWave Medical, Inc. Initiates Patient Screening in...
The Bradford Era· 6 days agoLucius Partners, LLC ("LP") today announced that its portfolio company, AerWave Medical, Inc., has begun screening patients for inclusion in First in Human (FIH) studies of the Company's unique ...
